These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Evolution of liver antioxidant status and iron implication during the development of deoxycorticosterone-saline hypertension in rats. Elhaïmeur F; Nicod L; Courderot-Masuyer C; Robin S; Guyon C; Bouhaddi M; Regnard J; Richert L; Berthelot A Biol Trace Elem Res; 2005 Dec; 107(3):263-76. PubMed ID: 16286682 [TBL] [Abstract][Full Text] [Related]
84. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis. Rickard AJ; Funder JW; Fuller PJ; Young MJ Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342 [TBL] [Abstract][Full Text] [Related]
85. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension. Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066 [TBL] [Abstract][Full Text] [Related]
86. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Leelahavanichkul A; Yan Q; Hu X; Eisner C; Huang Y; Chen R; Mizel D; Zhou H; Wright EC; Kopp JB; Schnermann J; Yuen PS; Star RA Kidney Int; 2010 Dec; 78(11):1136-53. PubMed ID: 20736988 [TBL] [Abstract][Full Text] [Related]
87. Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis. Young M; Funder J Endocrinology; 2003 Sep; 144(9):3848-51. PubMed ID: 12933657 [TBL] [Abstract][Full Text] [Related]
88. Does the Sabra hypertension-prone rat represent a model of salt or mineralocorticoid sensitivity? Yagil Y; Yagil C J Hypertens; 1998 Oct; 16(10):1481-4. PubMed ID: 9814619 [TBL] [Abstract][Full Text] [Related]
89. Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Griffin KA; Picken MM; Bidani AK Kidney Int; 2004 Jan; 65(1):209-18. PubMed ID: 14675052 [TBL] [Abstract][Full Text] [Related]
90. Effect of vitamin E therapy on serum uric acid in DOCA-salt-treated rats. Seifi B; Kadkhodaee M; Zahmatkesh M Acta Physiol Hung; 2011 Jun; 98(2):214-20. PubMed ID: 21616780 [TBL] [Abstract][Full Text] [Related]
91. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Machnik A; Dahlmann A; Kopp C; Goss J; Wagner H; van Rooijen N; Eckardt KU; Müller DN; Park JK; Luft FC; Kerjaschki D; Titze J Hypertension; 2010 Mar; 55(3):755-61. PubMed ID: 20142563 [TBL] [Abstract][Full Text] [Related]
92. Mineralocorticoid pretreatment enhances angiotensin II-induced neuronal excitation but not salt drinking in male Fischer rats. Omouessi ST; Falconetti C; Chapleur M; Fernette B; Thornton SN J Neuroendocrinol; 2007 Feb; 19(2):109-15. PubMed ID: 17214873 [TBL] [Abstract][Full Text] [Related]